Journal
CANCER CELL
Volume 14, Issue 1, Pages 68-78Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2008.05.017
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA111360, P01-CA098101, P01 CA098101, P30 CA016520, R01 CA111360-04, CA11360] Funding Source: Medline
Ask authors/readers for more resources
SCFFbx4 was recently identified as the E3 ligase for cyclin D1. We now describe cell-cycle-dependent phosphorylation and dimerization of Fbx4 that is regulated by GSK3 beta and is defective in human cancer. We present data demonstrating that a pathway involving Ras-Akt-GSK3 beta controls the temporal phosphorylation and dimerization of the SCFFbx4 E3 ligase. Inhibition of Fbx4 activity results in accumulation of nuclear cyclin D1 and oncogenic transformation. The importance of this regulatory pathway for normal cell growth is emphasized by the prevalence of mutations in Fbx4 in human cancer that impair dimerization. Collectively, these data reveal that inactivation of the cyclin D1 E3 ligase likely contributes to cyclin D1 overexpression in a significant fraction of human cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available